» Articles » PMID: 32038250

Three-Dimensional Culture Promotes the Differentiation of Human Dental Pulp Mesenchymal Stem Cells Into Insulin-Producing Cells for Improving the Diabetes Therapy

Overview
Journal Front Pharmacol
Date 2020 Feb 11
PMID 32038250
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Diabetes is a metabolic disease with a high incidence and serious harm to human health. Islet β-cell function defects can occur in the late stage of type 1 diabetes and type 2 diabetes. Studies have shown that stem cell is a promising new approach in bioengineering regenerative medicine. In the study of stem cell differentiation, three-dimensional (3D) cell culture is more capable of mimicking the microenvironment of cell growth than two-dimensional (2D) cell culture. The natural contact between cells and cells, and cells and extracellular matrix can regulate the development process and promote the formation of the artificial regenerative organs and organization. Type IV, VI collagen and laminin are the most abundant extracellular matrix components in islets. Matrigel, a basement membrane matrix biomaterial rich in laminin and collagen IV.

Materials And Methods: We used Matrigel biomaterial to physically embed human dental pulp stem cells (hDPSCs) to provide vector and 3D culture conditions for cells, and we explored and compared the preparation methods and preliminary mechanisms of differentiation of hDPSCs into insulin-producing cells (IPCs) under 2D or 3D culture conditions.We first designed and screened the strategy by mimicking the critical events of pancreatogenesis , and succeeded in establishing a new method for obtaining IPCs from hDPSCs. Activin A, Noggin, and small molecule compounds were used to synergistically induce hDPSCs to differentiate into definitive endoderm-like cells, pancreatic progenitor like cells and IPCs step by step under 2D culture conditions. Then, we used Matrigel to simulate the microenvironment , induced hDPSCs to differentiate into IPCs in Matrigel, evaluated and compared the efficiency between 2D and 3D culture conditions.

Results: The results showed that the synergistic combination of growth factors and small molecule compounds and 3D culture promoted the differentiation of hDPSCs into IPCs, significantly enhancing the release of insulin and C-peptide from IPCs.

Discussion: Significant support is provided for obtaining a large number of functional IPCs for disease modeling and final cell therapy in regenerative medicine.

Citing Articles

Mesenchymal Stem Cells and Their Extracellular Vesicles Are a Promising Alternative to Antibiotics for Treating Sepsis.

Jiang Y, Song Y, Zeng Q, Jiang B Bioengineering (Basel). 2024; 11(11).

PMID: 39593820 PMC: 11591657. DOI: 10.3390/bioengineering11111160.


Acquisition of durable insulin-producing cells from human adipose tissue-derived mesenchymal stem cells as a foundation for cell- based therapy of diabetes mellitus.

Nour Eldeen G, Aglan H, Mahmoud N, Abdel Rasheed M, Azmy O, Ahmed H Sci Rep. 2024; 14(1):24417.

PMID: 39424616 PMC: 11489467. DOI: 10.1038/s41598-024-74527-w.


Pancreatic Differentiation of Oral Minor Salivary Gland Stem Cells.

Pavlou A, Papachristou E, Bonovolias I, Anagnostou E, Anastasiadou P, Poulopoulos A Stem Cell Rev Rep. 2024; 20(7):1944-1953.

PMID: 38967770 DOI: 10.1007/s12015-024-10757-9.


The efficiency of stem cell differentiation into functional beta cells for treating insulin-requiring diabetes: Recent advances and current challenges.

Luo Y, Yu P, Liu J Endocrine. 2024; 86(1):1-14.

PMID: 38730069 DOI: 10.1007/s12020-024-03855-8.


3D Organoids for Regenerative Endodontics.

Li F, Kishen A Biomolecules. 2023; 13(6).

PMID: 37371480 PMC: 10296151. DOI: 10.3390/biom13060900.


References
1.
Stokes A, Preston S . Deaths Attributable to Diabetes in the United States: Comparison of Data Sources and Estimation Approaches. PLoS One. 2017; 12(1):e0170219. PMC: 5266275. DOI: 10.1371/journal.pone.0170219. View

2.
Millman J, Pagliuca F . Autologous Pluripotent Stem Cell-Derived β-Like Cells for Diabetes Cellular Therapy. Diabetes. 2017; 66(5):1111-1120. DOI: 10.2337/db16-1406. View

3.
Li K, Zhu S, Russ H, Xu S, Xu T, Zhang Y . Small molecules facilitate the reprogramming of mouse fibroblasts into pancreatic lineages. Cell Stem Cell. 2014; 14(2):228-36. PMC: 4747235. DOI: 10.1016/j.stem.2014.01.006. View

4.
Porat S, Dor Y . New sources of pancreatic beta cells. Curr Diab Rep. 2007; 7(4):304-8. DOI: 10.1007/s11892-007-0049-8. View

5.
Hering B, Clarke W, Bridges N, Eggerman T, Alejandro R, Bellin M . Phase 3 Trial of Transplantation of Human Islets in Type 1 Diabetes Complicated by Severe Hypoglycemia. Diabetes Care. 2016; 39(7):1230-40. PMC: 5317236. DOI: 10.2337/dc15-1988. View